Status:
NOT_YET_RECRUITING
Polymorphism of ITGA4 Gene in Chronic Lymphocytic Leukemia
Lead Sponsor:
Sohag University
Conditions:
Chronic Lymphocytic Leukemia
Eligibility:
All Genders
Brief Summary
Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder that is characterized by heterogeneous presentation at the clinical and molecular levels. ITGA4 protein has been found to be...
Eligibility Criteria
Inclusion
- Patients with newly diagnosed CLL.
Exclusion
- ▪ Patients previously diagnosed as CLL and received treatment before.
- Patients with other solid tumors.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05371392
Start Date
July 1 2024
End Date
October 1 2024
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university
Sohag, Egypt